F.R. Sallee

3.8k total citations · 1 hit paper
39 papers, 2.8k citations indexed

About

F.R. Sallee is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, F.R. Sallee has authored 39 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 17 papers in Clinical Psychology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in F.R. Sallee's work include Attention Deficit Hyperactivity Disorder (17 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Receptor Mechanisms and Signaling (11 papers). F.R. Sallee is often cited by papers focused on Attention Deficit Hyperactivity Disorder (17 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Receptor Mechanisms and Signaling (11 papers). F.R. Sallee collaborates with scholars based in United States, Switzerland and Canada. F.R. Sallee's co-authors include Douglas K. Kelsey, Joachim Wernicke, G. Sethuraman, Thomas Spencer, David Michelson, Katherine Kendrick, Douglas E. Faries, Donald L. Gilbert, Lauren Sine and Bruce G. Pollock and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

F.R. Sallee

39 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

2001 529 citations F.R. Sallee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F.R. Sallee United States	22	1.6k	1.4k	1000	344	253	39	2.8k
Fred Reimherr United States	34	2.6k 1.6×	858 0.6×	1.1k 1.1×	511 1.5×	303 1.2×	51	3.9k
Kory Schuh United States	27	1.3k 0.8×	371 0.3×	665 0.7×	317 0.9×	194 0.8×	58	2.4k
Sharon B. Wigal United States	38	3.6k 2.3×	968 0.7×	1.5k 1.5×	489 1.4×	976 3.9×	108	4.1k
Andrew J. Cutler United States	32	2.8k 1.7×	432 0.3×	521 0.5×	364 1.1×	179 0.7×	130	3.6k
Jean‐Philippe Boulenger France	29	745 0.5×	540 0.4×	481 0.5×	326 0.9×	136 0.5×	62	2.5k
Lutz Schmidt Germany	27	1.0k 0.6×	397 0.3×	467 0.5×	594 1.7×	53 0.2×	66	2.4k
Jeffrey A. Mattes United States	22	847 0.5×	378 0.3×	330 0.3×	176 0.5×	123 0.5×	45	1.3k
Stephen Cooper United Kingdom	34	1.4k 0.9×	484 0.3×	512 0.5×	648 1.9×	33 0.1×	87	2.9k
L. Cinnamon Bidwell United States	30	666 0.4×	395 0.3×	669 0.7×	280 0.8×	92 0.4×	100	2.3k
Christian Fleischhaker Germany	26	969 0.6×	982 0.7×	338 0.3×	121 0.4×	65 0.3×	83	1.8k

Countries citing papers authored by F.R. Sallee

Since Specialization

Citations

This map shows the geographic impact of F.R. Sallee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.R. Sallee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.R. Sallee more than expected).

Fields of papers citing papers by F.R. Sallee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.R. Sallee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.R. Sallee. The network helps show where F.R. Sallee may publish in the future.

Co-authorship network of co-authors of F.R. Sallee

This figure shows the co-authorship network connecting the top 25 collaborators of F.R. Sallee. A scholar is included among the top collaborators of F.R. Sallee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.R. Sallee. F.R. Sallee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faraone, Stephen V., et al.. (2017). Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family. Journal of Child and Adolescent Psychopharmacology. 27(8). 715–722. 21 indexed citations

Childress, Ann & F.R. Sallee. (2012). Revisiting clonidine: an innovative add-on option forattention-deficit/hyperactivity disorder. Drugs of today. 48(3). 207–207. 9 indexed citations

Ghosal, Sriparna, et al.. (2012). Attenuated stress‐evoked anxiety, increased sucrose preference and delayed spatial learning in glucocorticoid‐induced receptor‐deficient mice. Genes Brain & Behavior. 12(2). 241–249. 20 indexed citations

Childress, Ann, F.R. Sallee, & Susan A. Berry. (2011). Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD. Postgraduate Medicine. 123(5). 80–88. 10 indexed citations

Parker, Michael S., Renu Sah, A. Balasubramaniam, et al.. (2010). Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors. Peptides. 32(2). 258–265. 5 indexed citations

Cannon, Michael J., et al.. (2009). Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 19(5). 511–517. 22 indexed citations

Parker, Michael S., Renu Sah, Trevor W. Sweatman, et al.. (2009). Oligomerization of the Heptahelical G Protein Coupling Receptors: A Case for Association Using Transmembrane Helices (Supplimentry Material). Mini-Reviews in Medicinal Chemistry. 9(3). 329–339. 7 indexed citations

Parker, Steven L., Michael S. Parker, Renu Sah, et al.. (2008). The Neuropeptide Y (NPY) Y2 Receptors Are Largely Dimeric in the Kidney, but Monomeric in the Forebrain. Journal of Receptors and Signal Transduction. 28(3). 245–263. 8 indexed citations

Parker, Michael S., et al.. (2008). Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric. Regulatory Peptides. 150(1-3). 88–94. 10 indexed citations

10.

Parker, Michael S., Renu Sah, A. Balasubramaniam, et al.. (2008). Dimers of the Neuropeptide Y (NPY) Y2 Receptor Show Asymmetry in Agonist Affinity and Association with G Proteins. Journal of Receptors and Signal Transduction. 28(5). 437–451. 8 indexed citations

11.

Parker, Steven L., Michael S. Parker, F.R. Sallee, & A. Balasubramaniam. (2007). Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regulatory Peptides. 144(1-3). 72–81. 15 indexed citations

12.

Gilbert, Donald L., Jie Zhang, Tara D. Lipps, et al.. (2007). Atomoxetine treatment of ADHD in Tourette Syndrome: Reduction in motor cortex inhibition correlates with clinical improvement. Clinical Neurophysiology. 118(8). 1835–1841. 19 indexed citations

13.

Parker, Steven L., Michael S. Parker, Renu Sah, A. Balasubramaniam, & F.R. Sallee. (2006). Self-regulation of agonist activity at the Y receptors. Peptides. 28(2). 203–213. 12 indexed citations

14.

Parker, Steven L., Michael S. Parker, Renu Sah, F.R. Sallee, & A. Balasubramaniam. (2006). Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. Regulatory Peptides. 139(1-3). 128–135. 13 indexed citations

15.

Matza, Louis S., Kristina Secnik, Sally Mannix, & F.R. Sallee. (2005). Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK. PharmacoEconomics. 23(8). 777–790. 48 indexed citations

16.

Matza, Louis S., Kristina Secnik, Anne M. Rentz, et al.. (2005). Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Quality of Life Research. 14(3). 735–747. 37 indexed citations

17.

March, John S., Joseph Biederman, Robert Wolkow, et al.. (1998). Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder. JAMA. 280(20). 1752–1752. 322 indexed citations

18.

Hamamdzic, Damir, et al.. (1997). Expression of β-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Therapy. 4(8). 815–822. 37 indexed citations

19.

Sallee, F.R., et al.. (1997). Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. American Journal of Psychiatry. 154(5). 668–673. 52 indexed citations

20.

Sallee, F.R., et al.. (1994). Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder. Acta Psychiatrica Scandinavica. 90(1). 4–9. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact